SARS-CoV-2 IVD Immunoassay Development service

Antigen detection or antibody detection assays are commonly used serological diagnostic tools for viral infection. Creative Biolabs offers antibody development, antigen production, immunoassay development, and kit manufacturing services to improve the diagnostic level of SARS-CoV-2 infections.

Introduction to Coronavirus & SARS-CoV-2 Infection

Human coronaviruses, including hCoV-229E, OC43, NL63, and HKU1, cause mild respiratory diseases. However, fatal coronavirus infections have emerged, including the severe acute respiratory syndrome coronavirus (SARS-CoV), the Middle East respiratory syndrome coronavirus (MERS-CoV), and the SARS-CoV-2. The full-genome sequence analysis of SARS-CoV-2 revealed that it belongs to betacoronavirus. This novel coronavirus caused clusters of fatal pneumonia with clinical presentation greatly resembling SARS-CoV. Patients infected with SARS-CoV-2 might develop acute respiratory distress syndrome, have a high likelihood of admission to intensive care, and might die. At present, there are no vaccines or antivirals available for the treatment or prevention of SARS-CoV-2 infections. In the absence of virus-specific control measures, the key to controlling the spread of SARS-CoV-2 is rapid detection and isolation of suspect cases.

Learn more: SARS-CoV-2 IVD Immunoassay Development service